Al-Azhar university
Damietta, Egypt
NCT Number: NCT06752278
Management approaches for dry eye disease (DED) typically start with low-risk, easily accessible, patient-applied therapies like artificial tears for early-stage disease. As the condition worsens, treatment progresses to more advanced therapies for severe forms of DED. This study aims to compare the effectiveness and safety of pilocarpine as a secretagogue versus artificial tears in the treatment of dry eye disease. Our goal is to provide reliable, high-quality evidence regarding the efficacy of secretagogues, thereby contributing to the development of recommendations that aid clinicians in their decision-making process
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Damietta, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pilocarpine is a muscarinic agonist
artificial tears used for the treatment of Dry eye
Time frame: At the baseline and after 6 weeks
Time frame: At the baseline and after 6 weeks
Al-Azhar University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07175909
Dry Eye, Dry Eye Disease (DED)
Hong Kong
View Trial DetailsNCT07753811
Acne Vulgaris, Acneiform Eruptions
Banhā, Egypt
View Trial DetailsNCT07806240
Dry Eye Disease (DED), Dry Eye Syndromes
Beijing, China
View Trial DetailsNCT07243275
Dry Eye Disease (DED), Dry Eye Syndromes
Newport Beach, California, United States
View Trial Details